IS THERE A SURVIVAL BENEFIT FOR PATIENTS WHO RECEIVE POST-OPERATIVE ADJUVANT CHEMOTHERAPY FOLLOWING SECONDARY CYTOREDUCTIVE SURGERY (SCRS) FOR RECURRENT EPITHELIAL OVARIAN CANCER (EOC)?

被引：0
|
作者：
Kolomainen, D. F. [1 ]
Butler, J. [1 ]
Barton, D. P. J. [1 ]
Ind, T. E. J. [1 ]
Nobbenhuis, M. A. E. [1 ]
Lalondrelle, S. [1 ]
Taylor, A. [1 ]
Shepherd, J. H. [1 ]
Gore, M. E. [1 ]
Kaye, S. B. [1 ]
Banerjee, S. [1 ]
机构：
[1] Royal Marsden Hosp, Gynaecol Canc Unit, London SW3 6JJ, England
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-0631
引用
收藏
页码：1407 / 1407
页数：1
相关论文
共 50 条
  • [21] Model for prediction of delayed chemotherapy following cytoreductive surgery in patients with epithelial ovarian cancer
    Newlin, E. M.
    Connor, E. V.
    Han, X.
    Mahdi, H.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 192 - 193
  • [22] IMPACT OF PRE-OPERATIVE HYPOABUMINEMIA ON POST-OPERATIVE MORBIDITY AND OVERALL SURVIVAL IN OVARIAN CANCER UNDERGOING CYTOREDUCTIVE SURGERY
    Ataseven, B.
    du Bois, A.
    Reinthaller, A.
    Traut, A.
    Heitz, F.
    Aust, S.
    Prader, S.
    Polterauer, S.
    Harter, P.
    Grimm, C.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 384 - 384
  • [23] Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer - Analysis of prognostic factors and survival outcome
    Salani, Ritu
    Santillan, Antonio
    Zahurak, Marianna L.
    Giuntoli, Robert L., II
    Gardner, Ginger J.
    Armstrong, Deborah K.
    Bristow, Robert E.
    [J]. CANCER, 2007, 109 (04) : 685 - 691
  • [24] Predictors of Post-operative Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer with Peritoneal Carcinomatosis
    Chin, K.
    Tan, G.
    Shulyn, C. Chia
    Ong, J.
    Teo, M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S162 - S162
  • [25] Long-term survival in patients with epithelial ovarian cancer following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Le Saux, Olivia
    Decullier, Evelyne
    Freyer, Gilles
    Glehen, Olivier
    Bakrin, Naoual
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 35 (01) : 652 - 657
  • [26] Mechanical bowel preparation and post-operative renal dysfunction in patients undergoing cytoreductive surgery for ovarian cancer
    Al-Niaimi, Ahmed
    Alrubaye, Rana
    Wang, Connor
    Tran, Vienna
    Montemorano, Lauren
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S4 - S4
  • [27] Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study
    Deraco, M.
    Virzi, S.
    Iusco, D. R.
    Puccio, F.
    Macri, A.
    Famulari, C.
    Solazzo, M.
    Bonomi, S.
    Grassi, A.
    Baratti, D.
    Kusamura, S.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (07) : 800 - 809
  • [28] Post-operative pancreatic fistula following splenectomy with or without distal pancreatectomy at cytoreductive surgery in advanced ovarian cancer
    Bizzarri, Nicolo
    Korompelis, Porfyrios
    Ghirardi, Valentina
    O'Donnell, Rachel Louise
    Rundle, Stuart
    Naik, Raj
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (07) : 1043 - 1051
  • [29] INTERVAL BETWEEN CYTOREDUCTIVE SURGERY AND ADJUVANT CHEMOTHERAPY IS ASSOCIATED WITH OVERALL SURVIVAL IN PATIENTS WITH ADVANCED OVARIAN CANCER
    Timmermans, M.
    van der Aa, M. A.
    Van de Vijver, K. K.
    Kruitwagen, R. F. P. M.
    Sonke, G. S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 41 - 41
  • [30] INTERVAL BETWEEN CYTOREDUCTIVE SURGERY AND ADJUVANT CHEMOTHERAPY IS ASSOCIATED WITH OVERALL SURVIVAL IN PATIENTS WITH ADVANCED OVARIAN CANCER
    Timmermans, M.
    van der Aa, M. A.
    Van de Vijver, K. K.
    Kruitwagen, R. F. P. M.
    Sonke, G. S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1692 - 1692
12345